1 1 AB UK Medical Ltd 09373419 false 2023-03-29 2024-03-26 2024-03-26 The principal activity of the company is General medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 09373419 2023-03-29 2024-03-26 09373419 2024-03-26 09373419 core:CurrentFinancialInstruments 2024-03-26 09373419 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-26 09373419 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-26 09373419 core:FurnitureFittingsToolsEquipment 2024-03-26 09373419 bus:SmallEntities 2023-03-29 2024-03-26 09373419 bus:AuditExemptWithAccountantsReport 2023-03-29 2024-03-26 09373419 bus:FilletedAccounts 2023-03-29 2024-03-26 09373419 bus:SmallCompaniesRegimeForAccounts 2023-03-29 2024-03-26 09373419 bus:RegisteredOffice 2023-03-29 2024-03-26 09373419 bus:Director2 2023-03-29 2024-03-26 09373419 bus:PrivateLimitedCompanyLtd 2023-03-29 2024-03-26 09373419 core:ComputerEquipment 2023-03-29 2024-03-26 09373419 core:FurnitureFittingsToolsEquipment 2023-03-29 2024-03-26 09373419 countries:AllCountries 2023-03-29 2024-03-26 09373419 2023-03-28 09373419 core:FurnitureFittingsToolsEquipment 2023-03-28 09373419 2022-03-30 2023-03-28 09373419 2023-03-28 09373419 core:CurrentFinancialInstruments 2023-03-28 09373419 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-28 09373419 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-28 09373419 core:FurnitureFittingsToolsEquipment 2023-03-28 xbrli:pure iso4217:GBP

Registration number: 09373419

AB UK Medical Ltd

Unaudited Filleted Financial Statements

for the Period from 29 March 2023 to 26 March 2024

 

AB UK Medical Ltd

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 3

 

AB UK Medical Ltd

(Registration number: 09373419)
Balance Sheet as at 26 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

-

37

Current assets

 

Debtors

5

-

714

Cash at bank and in hand

 

3,002

675

 

3,002

1,389

Creditors: Amounts falling due within one year

6

(19,066)

(17,244)

Net current liabilities

 

(16,064)

(15,855)

Total assets less current liabilities

 

(16,064)

(15,818)

Creditors: Amounts falling due after more than one year

6

(48,095)

(48,095)

Provisions for liabilities

(1)

(8)

Net liabilities

 

(64,160)

(63,921)

Capital and reserves

 

Called up share capital

2

2

Retained earnings

(64,162)

(63,923)

Shareholders' deficit

 

(64,160)

(63,921)

For the financial period ending 26 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 25 March 2025
 

.........................................
Dr Adam Beaini
Director

 

AB UK Medical Ltd

Notes to the Financial Statements for the Period from 29 March 2023 to 26 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England and wales.

The address of its registered office is:
Auker Rhodes
Basement Floor
Focus House, Focus Way
Yeadon
LS19 7DB

These financial statements were authorised for issue by the director on 25 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

At the balance sheet date the company had net liabilities of £64,160 (£63,921). The director consider it appropriate to prepare the financial statements on the going concern basis, despite the technical insolvency of the company.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

33.33% straight line (Fully written-off)

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1 (2023 - 1).

 

AB UK Medical Ltd

Notes to the Financial Statements for the Period from 29 March 2023 to 26 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 29 March 2023

2,896

2,896

At 26 March 2024

2,896

2,896

Depreciation

At 29 March 2023

2,859

2,859

Charge for the period

37

37

At 26 March 2024

2,896

2,896

Carrying amount

At 26 March 2024

-

-

At 28 March 2023

37

37

5

Debtors

Current

2024
£

2023
£

Other debtors

-

714

 

-

714

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Trade creditors

 

1,860

1,760

Other creditors

 

17,206

15,484

 

19,066

17,244

Due after one year

 

Loans and borrowings

48,095

48,095